PROSPECTS AND OPPORTUNITIES
Continued growth, with more targeted products likely to be seen
Analgesics in Brazil is set to maintain solid retail current value growth throughout the forecast period, with increasing sales anticipated across all categories. Dipyrone is set to see the strongest growth in the forecast period, due to the emergence of dengue outbreaks, as one of the most effective treatments.
Changing demographics set to impact sales of analgesics
Growth in the forecast period will partly be due to the constant rise in the population in Brazil. Moreover, Brazil is undergoing one of the fastest demographic transitions in the world, with the ageing of the population.
Move towards retail e-commerce along with rise of single-person households
Independent pharmacies still account for most sales of analgesics in Brazil, and this is expected to remain the case in the forecast period. Many such stores join cooperative networks that offer better purchasing conditions for the retailers, increasing the scale of negotiations with suppliers and bringing more competitive advantages in terms of final prices.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Brazil with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Brazil, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Brazil report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Brazil?
- Which are the leading brands in Analgesics in Brazil?
- How are products distributed in Analgesics in Brazil?
- How has the regulatory and operating environment for Analgesics changed in Brazil?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Brazil - Category analysis
KEY DATA FINDINGS
As consumers value efficacy, analgesics maintains growth from a high base
Several growth drivers contribute to positive performance
Dorflex continues to lead thanks to constant development
Continued growth, with more targeted products likely to be seen
Changing demographics set to impact sales of analgesics
Move towards retail e-commerce along with rise of single-person households
Consumer Health in Brazil - Industry Overview
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!